Us Congress House Bill HB586

Us Congress 2025-2026 Regular Session

• Introduced: 1/21/25
• Refer: 1/21/25
• Refer: 2/25/25
• Engrossed: 4/8/25

Caption

Vietnam Veterans Liver Fluke Cancer Study ActThis bill requires the Department of Veterans Affairs (VA) to conduct an epidemiological study and report on the prevalence of cholangiocarcinoma (bile duct cancer) in veterans who served in the Vietnam theater of operations during the Vietnam era. The study must identify the rate of incidence of cholangiocarcinoma in such veterans and in U.S. residents.The bill also requires the VA to track and report on the prevalence of cholangiocarcinoma using the Veterans Affairs Central Cancer Registry. Additionally, the VA must periodically submit follow-up reports to Congress regarding the epidemiological study and information collected from the cancer registry regarding the prevalence of bile duct cancer.

Impact

The passage of HB 586 indicates an increased recognition of health issues affecting veterans, especially those who served in Vietnam. By institutionalizing this study, the bill aims to address potential links between service and harmful health outcomes, potentially leading to increased healthcare support and resources for affected veterans. The insights gained from the study could inform future legislation regarding healthcare provisions and support programs specifically aimed at veterans suffering from cholangiocarcinoma and related health issues.

Summary

House Bill 586, also known as the Vietnam Veterans Liver Fluke Cancer Study Act, aims to investigate the prevalence of cholangiocarcinoma, a form of cancer, among veterans who served in the Vietnam theater during the Vietnam War. The bill mandates the Secretary of Veterans Affairs to initiate an epidemiological study within 120 days post-enactment, utilizing data from the Veterans Affairs Central Cancer Registry and the National Program of Cancer Registries. The findings from this study will provide essential data on the incidence rates among veterans compared to the general U.S. population, considering various demographic factors.

Sentiment

Support for HB 586 is generally positive, especially within veteran advocacy groups who view it as a necessary step towards understanding and addressing the health concerns of Vietnam-era veterans. Proponents underscore the importance of comprehensive research on health issues that disproportionately affect this demographic. However, there may be some contention regarding the urgency and allocation of resources for such studies, reflecting broader debates about healthcare funding and prioritization in veteran affairs.

Contention

One notable point of contention surrounding HB 586 could be the potential impacts of its findings on administrative or legislative actions. The study's results may lead to calls for enhanced healthcare coverage or support services specifically tailored for veterans with cholangiocarcinoma. Furthermore, the bill includes provisions for the Secretary to regularly report back to Congress, which may stimulate ongoing discussions regarding the adequacy of current veteran healthcare policies and the effectiveness of VA resources.

Congress_id

119-HR-586

Policy_area

Armed Forces and National Security

Introduced_date

2025-01-21